Capital Flow Monitor · Sponsors · CIK 1583771
Hepion Pharmaceuticals, Inc.
34 SHREWSBURY AVE., RED BANK, NJ, 07701 · (732) 902-4000
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$3.1M
Sold
$3.1M
% sold
100.0%
Investors
33
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-08-05 | D ·current | 506(b) | $3.1M | $3.1M | 100.0% | 33 | EDGAR ↗ |
| 2026-04-22 | D | 506(b) | $700K | $700K | 100.0% | 11 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Gary Stetz — Executive Officer / Director, Red Bank, NJ
1 other raise
- Canton Strategic Holdings, Inc. $2.5M of $2.5M · 100.0%
-
Vincent LoPriore — Executive Officer / Director, Red Bank, NJ
1 other raise
- Canton Strategic Holdings, Inc. $2.5M of $2.5M · 100.0%
-
Sireesh Appajosyula — Director, Red Bank, NJ
1 other raise
- Canton Strategic Holdings, Inc. $2.5M of $2.5M · 100.0%
- Chase LoPriore — Director, Red Bank, NJ
- Michael Purcell — Director, Red Bank, NJ
- Dania Fisher — Director, Red Bank, NJ
- Gary S. Stetz, II — Director, Red Bank, NJ
Placement agents
- Not Applicable · 2 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.